Peer Exchange

Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.

Economic Burden and Challenges of Trial of SMA
July 22, 2019 – 
The panel shed a light on the economic burden of spinal muscular atrophy and the challenges of trial design.
Diagnostic Tests and Scales of SMA
July 22, 2019 – 
John Brandsema, MD, discusses the diagnostic process for spinal muscular atrophy, including the different functional motor scales used to measure patient function.

 
Practical Implications of the MAIA Study for MM
July 19, 2019 – 
Experts discuss the practical implications of the MAIA study for patients with newly diagnosed transplant-ineligible multiple myeloma.
Initiating Treatment in Relapsed-Refractory MM
July 19, 2019 – 
Discussion on the personal approaches toward treatment for patients with relapsed or refractory multiple myeloma.
What Is the Cost of Recurrence in Multiple Myeloma?
July 19, 2019 – 
Experts review the economic factors that play into the high costs of treatment and care for patients with multiple myeloma.
Osteoporosis: Selecting Between Novel Therapies
July 19, 2019 – 
Factors that affect a clinician’s willingness to recommend a novel treatment option for the management of osteoporosis.
Romosozumab in Clinical Trials for Osteoporosis
July 19, 2019 – 
Perspective regarding the rationale for treating patients with osteoporosis with romosozumab based on recent clinical trials.
Considerations for Transplant-Ineligible Patients
July 19, 2019 – 
Experts discuss how neuropathy plays a part in the treatment decisions for therapy in patients with multiple myeloma, who are ineligible for transplant.
Prior Authorization and Payer Test Coverage of SMA
July 15, 2019 – 
The panel discusses the steps required for prior authorization and which tests are covered and required by the payer.
 
Payer Diagnostic Criteria and Prior Authorization of SMA
July 15, 2019 – 
Surya Singh, MD, provides insights on the diagnostic criteria for spinal muscular atrophy and the review the prior authorization process.
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.